Advertisement

Journal of Cancer Survivorship

, Volume 13, Issue 6, pp 968–980 | Cite as

Patient-clinician interactions and disparities in breast cancer care: the equality in breast cancer care study

  • Felisa A. Gonzales
  • Meera Sangaramoorthy
  • Laura A. Dwyer
  • Salma Shariff-Marco
  • Amani M. Allen
  • Allison W. Kurian
  • Juan Yang
  • Michelle M. Langer
  • Laura Allen
  • Bryce B. Reeve
  • Stephen H. Taplin
  • Scarlett Lin GomezEmail author
Article

Abstract

Purpose

To examine whether interpersonal aspects of patient-clinician interactions, such as patient-perceived medical discrimination, clinician mistrust, and treatment decision-making contribute to racial/ethnic/educational disparities in breast cancer care.

Methods

A telephone interview was administered to 542 Asian/Pacific Islander (API), Black, Hispanic, and White women identified through the Greater Bay Area Cancer Registry, ages 20 and older diagnosed with a first primary invasive breast cancer. Adjusted odds ratios (aOR) and 95% confidence intervals (CI) were calculated from logistic regression models that assessed associations between race/ethnicity/education, medical discrimination, clinician mistrust, and treatment decision-making with concordance to breast cancer treatment guidelines (guideline-concordant treatment) and perceived quality of care (pQoC).

Results

Approximately three-quarters of women received treatment that was guideline-concordant (76.6%) and reported that their breast cancer care was excellent (72.1%). Non-college-educated Black women had lower odds of guideline-concordant care (aOR (CI) = 0.29 (0.12–0.67)) vs. college-educated White women. Odds of excellent pQoC were lower among the following: college-educated Hispanic women (aOR (CI) = 0.09 (0.02–0.47)) and API women regardless of education (aORs ≤ 0.50) vs. college-educated White women, women reporting low and moderate levels of discrimination (aORs ≤ 0.44) vs. none, and women reporting any clinician mistrust (aOR (CI) = 0.50 (0.29–0.88)) vs. none. Disparities in guideline-concordant care and pQoC persisted after controlling for medical discrimination, clinician mistrust, and decision-making.

Conclusions

Interpersonal aspects of the patient-clinician interaction had an impact on pQoC but not receipt of guideline-concordant treatment and did not explain disparities in either outcome.

Implications for Cancer Survivors

Although breast cancer survivors’ interpersonal interactions with clinicians did not influence receipt of appropriate treatment, intervention strategies to improve patient-clinician relations may help attenuate disparities in survivors’ pQoC.

Keywords

Disparities Breast cancer Discrimination Decision-making Mistrust 

Notes

Acknowledgments

We would like to thank Dr. Gem Le, Dr. Thu Quach, the staff of the Equality in Breast Cancer Care (EBCC) Study, and the EBCC participants for their contributions to this study.

Funding information

The collection of cancer incidence data used in this study was supported by the California Department of Public Health pursuant to California Health and Safety Code Section 103885; Centers for Disease Control and Prevention’s (CDC) National Program of Cancer Registries, under cooperative agreement 5NU58DP006344; the National Cancer Institute’s Surveillance, Epidemiology and End Results Program under contract HHSN261201800032I awarded to the University of California, San Francisco, contract HHSN261201800015I awarded to the University of Southern California, and contract HHSN261201800009I awarded to the Public Health Institute, Cancer Registry of Greater California. The ideas and opinions expressed herein are those of the author(s) and do not necessarily reflect the opinions of the State of California, Department of Public Health, the National Cancer Institute, and the Centers for Disease Control and Prevention or their Contractors and Subcontractors.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    National Cancer Institute S, Epidemiology, and End Results Program. SEER Stat Fact Sheets: Female Breast Cancer. http://seer.cancer.gov/statfacts/html/breast.html. Accessed March 25 2016.
  2. 2.
    Shariff-Marco S, Yang J, John EM, Kurian AW, Cheng I, Leung R, et al. Intersection of race/ethnicity and socioeconomic status in mortality after breast cancer. J Community Health. 2015;40(6):1287–99.  https://doi.org/10.1007/s10900-015-0052-y.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66(1):31–42.  https://doi.org/10.3322/caac.21320.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Kohler BA, Sherman RL, Howlader N, Jemal A, Ryerson AB, Henry KA, et al. Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst. 2015;107(6):djv048.  https://doi.org/10.1093/jnci/djv048.CrossRefPubMedCentralGoogle Scholar
  5. 5.
    Wheeler SB, Reeder-Hayes KE, Carey LA. Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research. Oncologist. 2013;18(9):986–93.  https://doi.org/10.1634/theoncologist.2013-0243.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Chen L, Li CI. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status. Cancer Epidemiol Biomark Prev. 2015.  https://doi.org/10.1158/1055-9965.epi-15-0293.CrossRefGoogle Scholar
  7. 7.
    Wu X, Richardson LC, Kahn AR, Fulton JP, Cress RD, Shen T, et al. Survival difference between non-Hispanic black and non-Hispanic white women with localized breast cancer: the impact of guideline-concordant therapy. J Natl Med Assoc. 2008;100(5):490–8.CrossRefGoogle Scholar
  8. 8.
    Kurian AW, Lichtensztajn DY, Keegan TH, Nelson DO, Clarke CA, Gomez SL. Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011. Jama. 2014;312(9):902–14.  https://doi.org/10.1001/jama.2014.10707.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Maly RC, Stein JA, Umezawa Y, Leake B, Anglin MD. Racial/ethnic differences in breast cancer outcomes among older patients: effects of physician communication and patient empowerment. Health psychology : official journal of the Division of Health Psychology, American Psychological Association. 2008;27(6):728–36.  https://doi.org/10.1037/0278-6133.27.6.728.CrossRefGoogle Scholar
  10. 10.
    Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003;163(1):49–56.CrossRefGoogle Scholar
  11. 11.
    Gomez SL, Press DJ, Lichtensztajn D, Keegan TH, Shema SJ, Le GM, et al. Patient, hospital, and neighborhood factors associated with treatment of early-stage breast cancer among Asian American women in California. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2012;21(5):821–34.  https://doi.org/10.1158/1055-9965.epi-11-1143.CrossRefGoogle Scholar
  12. 12.
    Palmer NR, Kent EE, Forsythe LP, Arora NK, Rowland JH, Aziz NM, et al. Racial and ethnic disparities in patient-provider communication, quality-of-care ratings, and patient activation among long-term cancer survivors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014;32(36):4087–94.  https://doi.org/10.1200/jco.2014.55.5060.CrossRefGoogle Scholar
  13. 13.
    Bickell NA, Neuman J, Fei K, Franco R, Joseph KA. Quality of breast cancer care: perception versus practice. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(15):1791–5.  https://doi.org/10.1200/jco.2011.38.7605.CrossRefGoogle Scholar
  14. 14.
    Taplin SH, Anhang Price R, Edwards HM, Foster MK, Breslau ES, Chollette V, et al. Introduction: understanding and influencing multilevel factors across the cancer care continuum. J Natl Cancer Inst Monogr. 2012;2012(44):2–10.  https://doi.org/10.1093/jncimonographs/lgs008.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Bickell NA, Weidmann J, Fei K, Lin JJ, Leventhal H. Underuse of breast cancer adjuvant treatment: patient knowledge, beliefs, and medical mistrust. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27(31):5160–7.  https://doi.org/10.1200/jco.2009.22.9773.CrossRefGoogle Scholar
  16. 16.
    Katz SJ, Lantz PM, Janz NK, Fagerlin A, Schwartz K, Liu L, et al. Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(24):5526–33.  https://doi.org/10.1200/jco.2005.06.217.CrossRefGoogle Scholar
  17. 17.
    Gerend MA, Pai M. Social determinants of Black-White disparities in breast cancer mortality: a review. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2008;17(11):2913–23.  https://doi.org/10.1158/1055-9965.epi-07-0633.CrossRefGoogle Scholar
  18. 18.
    (IOM) IoM. Unequal treatment: confronting racial and ethnic disparities in health care. Washington, DC: National Academies Press; 2003.Google Scholar
  19. 19.
    Jary D, Jary J. Collins Dictionary of Sociology. 2nd ed. ed. Glasgow, UK: HarperCollins; 1995.Google Scholar
  20. 20.
    Shavers VL, Fagan P, Jones D, Klein WM, Boyington J, Moten C, et al. The state of research on racial/ethnic discrimination in the receipt of health care. Am J Public Health. 2012;102(5):953–66.  https://doi.org/10.2105/ajph.2012.300773.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Shariff-Marco S, Klassen AC, Bowie JV. Racial/ethnic differences in self-reported racism and its association with cancer-related health behaviors. Am J Public Health. 2010;100(2):364–74.  https://doi.org/10.2105/ajph.2009.163899.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Taylor TR, Williams CD, Makambi KH, Mouton C, Harrell JP, Cozier Y, et al. Racial discrimination and breast cancer incidence in US Black women: the Black Women’s Health Study. Am J Epidemiol. 2007;166(1):46–54.  https://doi.org/10.1093/aje/kwm056.CrossRefPubMedGoogle Scholar
  23. 23.
    LaVeist TA, Nickerson KJ, Bowie JV. Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients. Medical Care Research and Review : MCRR. 2000;57(Suppl 1):146–61.CrossRefGoogle Scholar
  24. 24.
    Sorkin DH, Ngo-Metzger Q, De Alba I. Racial/ethnic discrimination in health care: impact on perceived quality of care. J Gen Intern Med. 2010;25(5):390–6.  https://doi.org/10.1007/s11606-010-1257-5.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Lam WW, Kwok M, Chan M, Hung WK, Ying M, Or A, et al. Does the use of shared decision-making consultation behaviors increase treatment decision-making satisfaction among Chinese women facing decision for breast cancer surgery? Patient Educ Couns. 2014;94(2):243–9.  https://doi.org/10.1016/j.pec.2013.11.006.CrossRefPubMedGoogle Scholar
  26. 26.
    Lopez ME, Kaplan CP, Napoles AM, Hwang ES, Livaudais JC, Karliner LS. Satisfaction with treatment decision-making and treatment regret among Latinas and non-Latina whites with DCIS. Patient Educ Couns. 2014;94(1):83–9.  https://doi.org/10.1016/j.pec.2013.09.005.CrossRefPubMedGoogle Scholar
  27. 27.
    Lewis TT, Cogburn CD, Williams DR. Self-reported experiences of discrimination and health: scientific advances, ongoing controversies, and emerging issues. Annu Rev Clin Psychol. 2015;11:407–40.  https://doi.org/10.1146/annurev-clinpsy-032814-112728.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Williams DR, Kontos EZ, Viswanath K, Haas JS, Lathan CS, MacConaill LE, et al. Integrating multiple social statuses in health disparities research: the case of lung cancer. Health Serv Res. 2012;47(3 Pt 2):1255–77.  https://doi.org/10.1111/j.1475-6773.2012.01404.x.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Reuben SH, Milliken EL, Paradis LJ. America’s demographic and cultural transformation: implications for cancer. Bethesda, MD: National Cancer Institute; 2011.Google Scholar
  30. 30.
    Stepanikova I, Oates GR. Perceived discrimination and privilege in health care: the role of socioeconomic status and race. Am J Prev Med. 52(1):S86–94.  https://doi.org/10.1016/j.amepre.2016.09.024.CrossRefGoogle Scholar
  31. 31.
    Shih T-H, Fan X. Comparing response rates in e-mail and paper surveys: a meta-analysis. Educational Research Review. 2009;4(1):26–40.  https://doi.org/10.1016/j.edurev.2008.01.003.CrossRefGoogle Scholar
  32. 32.
    National Comprehensive Cancer Network Breast Cancer Guidelines. https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site. Accessed April 20 2016.
  33. 33.
    Kurian AW, Lichtensztajn DY, Keegan TH, Leung RW, Shema SJ, Hershman DL, et al. Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. Breast Cancer Res Treat. 2013;137(1):247–60.  https://doi.org/10.1007/s10549-012-2329-5.CrossRefPubMedGoogle Scholar
  34. 34.
    Blayney DW, McNiff K, Hanauer D, Miela G, Markstrom D, Neuss M. Implementation of the Quality Oncology Practice Initiative at a university comprehensive cancer center. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27(23):3802–7.  https://doi.org/10.1200/jco.2008.21.6770.CrossRefGoogle Scholar
  35. 35.
    Malin JL, Ko C, Ayanian JZ, Harrington D, Nerenz DR, Kahn KL, et al. Understanding cancer patients’ experience and outcomes: development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. 2006;14(8):837–48.  https://doi.org/10.1007/s00520-005-0902-8.CrossRefGoogle Scholar
  36. 36.
    Kehl KL, Landrum MB, Arora NK, Ganz PA, van Ryn M, Mack JW, et al. Association of actual and preferred decision roles with patient-reported quality of care: shared decision making in cancer care. JAMA oncology. 2015;1(1):50–8.  https://doi.org/10.1001/jamaoncol.2014.112.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Williams DR, Yan Y, Jackson JS, Anderson NB. Racial Differences in physical and mental health: socio-economic status, stress and discrimination. J Health Psychol. 1997;2(3):335–51.  https://doi.org/10.1177/135910539700200305.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Quach T, Nuru-Jeter A, Morris P, Allen L, Shema SJ, Winters JK, et al. Experiences and perceptions of medical discrimination among a multiethnic sample of breast cancer patients in the Greater San Francisco Bay Area, California. Am J Public Health. 2012;102(5):1027–34.  https://doi.org/10.2105/ajph.2011.300554.CrossRefPubMedCentralGoogle Scholar
  39. 39.
    Shariff-Marco S, Gonzales FA, Langer MM, Dwyer LA, Nuru-Jeter A, Allen L et al. Measuring medical discrimination in a diverse cohort of breast cancer patients: equality in breast cancer care study. 2016 (in preparation).Google Scholar
  40. 40.
    Sen G, Iyer A, Mukherjee C. A methodology to analyse the intersections of social inequalities in health. Journal of Human Development and Capabilities. 2009;10(3):397–415.  https://doi.org/10.1080/19452820903048894.CrossRefGoogle Scholar
  41. 41.
    Vandergrift JL, Niland JC, Theriault RL, Edge SB, Wong YN, Loftus LS, et al. Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions. J Natl Cancer Inst. 2013;105(2):104–12.  https://doi.org/10.1093/jnci/djs506.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Rosenzweig MQ, Wiehagen T, Brufsky A, Arnold R. Challenges of illness in metastatic breast cancer: a low-income African American perspective. Palliative & supportive care. 2009;7(2):143–52.  https://doi.org/10.1017/s1478951509000194.CrossRefGoogle Scholar
  43. 43.
    Jagsi R, Pottow JA, Griffith KA, Bradley C, Hamilton AS, Graff J, et al. Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014;32(12):1269–76.  https://doi.org/10.1200/jco.2013.53.0956.CrossRefGoogle Scholar
  44. 44.
    (IOM) IoM. Delivering high-quality cancer care: charting a new course for a system in crisis. Washington, DC: National Academies Press; 2013.Google Scholar
  45. 45.
    Abraido-Lanza AF, Echeverria SE, Florez KR. Latino immigrants, acculturation, and health: promising new directions in research. Annu Rev Public Health. 2016;37:219–36.  https://doi.org/10.1146/annurev-publhealth-032315-021545.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Yoon H, Chatters L, Kao TS, Saint-Arnault D, Northouse L. Factors affecting quality of life for Korean American cancer survivors: an integrative review. Oncol Nurs Forum. 2016;43(3):E132–42.  https://doi.org/10.1188/16.ONF.E132-E142.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Farias AJ, Ornelas IJ, Hohl SD, Zeliadt SB, Hansen RN, Li CI, et al. Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2017;25(1):75–83.  https://doi.org/10.1007/s00520-016-3389-6.CrossRefGoogle Scholar
  48. 48.
    Burgess D, van Ryn M, Dovidio J, Saha S. Reducing racial bias among health care providers: lessons from social-cognitive psychology. J Gen Intern Med. 2007;22(6):882–7.  https://doi.org/10.1007/s11606-007-0160-1.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Glicksman E. Unconscious bias in academic medicine: Overcoming the prejudices we don't know we have. Association of American Medical Colleges, Washington, DC. 2016, January. https://www.aamc.org/news-insights/unconscious-bias-academic-medicine-overcoming-prejudices-we-don-t-know-we-have. Accessed July 8 2016.
  50. 50.
    Greenwald AG, McGhee DE, Schwartz JL. Measuring individual differences in implicit cognition: the implicit association test. J Pers Soc Psychol. 1998;74(6):1464–80.  https://doi.org/10.1037//0022-3514.74.6.1464.CrossRefGoogle Scholar
  51. 51.
    FitzGerald C, Hurst S. Implicit bias in healthcare professionals: a systematic review. BMC Med Ethics. 2017;18(1):19.  https://doi.org/10.1186/s12910-017-0179-8.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Kool M, Bastiaannet E, Van de Velde CJH. Marang-van de Mheen PJ. Reliability of self-reported treatment data by patients with breast cancer compared with medical record data. Clin Breast Cancer. 2018;18(3):234–8.  https://doi.org/10.1016/j.clbc.2017.08.005.CrossRefPubMedGoogle Scholar
  53. 53.
    Liu Y, Diamant AL, Thind A, Maly RC. Validity of self-reports of breast cancer treatment in low-income, medically underserved women with breast cancer. Breast Cancer Res Treat. 2010;119(3):745–51.  https://doi.org/10.1007/s10549-009-0447-5.CrossRefPubMedGoogle Scholar
  54. 54.
    Phillips KA, Milne RL, Buys S, Friedlander ML, Ward JH, McCredie MR, et al. Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(21):4679–86.  https://doi.org/10.1200/JCO.2005.03.002.CrossRefGoogle Scholar
  55. 55.
    Krieger N. Discrimination and health inequities. In: Berkman L, Kawachi I, Glymour M, editors. Social Epidemiology. New York, NY: Oxford University Press; 2014. p. 63–125.Google Scholar
  56. 56.
    Society AC. Breast cancer. 2016. http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-key-statistics. Accessed March 25, 2016 2016.

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Felisa A. Gonzales
    • 1
  • Meera Sangaramoorthy
    • 2
  • Laura A. Dwyer
    • 3
  • Salma Shariff-Marco
    • 2
    • 4
  • Amani M. Allen
    • 5
  • Allison W. Kurian
    • 6
    • 7
  • Juan Yang
    • 2
  • Michelle M. Langer
    • 8
  • Laura Allen
    • 2
  • Bryce B. Reeve
    • 9
  • Stephen H. Taplin
    • 10
  • Scarlett Lin Gomez
    • 2
    • 4
    Email author
  1. 1.Division of Cancer Control and Population Sciences, The Colorado TrustNational Cancer InstituteRockvilleUSA
  2. 2.Department of Epidemiology & Biostatistics, School of MedicineUniversity of California San FranciscoSan FranciscoUSA
  3. 3.Cape Fox Facilities ServicesManassasUSA
  4. 4.Helen Diller Family Comprehensive Cancer CenterUniversity of California San FranciscoSan FranciscoUSA
  5. 5.School of Public HealthUniversity of California BerkeleyBerkeleyUSA
  6. 6.Health Research & Policy (Epidemiology), School of MedicineStanford UniversityStanfordUSA
  7. 7.Stanford Cancer InstituteStanford UniversityStanfordUSA
  8. 8.Department of Medical Social Sciences, Feinberg School of MedicineNorthwestern UniversityEvanstonUSA
  9. 9.Center for Health MeasurementDuke University School of MedicineDurhamUSA
  10. 10.Center for Global HealthNational Cancer InstituteRockvilleUSA

Personalised recommendations